"Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The UP Study"

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

May 13, 2021

Study Completion Date

May 13, 2021

Conditions

Parkinson's Disease

Interventions

DRUG

Ursonorm

Ursodeoxycholic acid

Trial Locations (2)

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

University College London Institute of Neurology, London

All Listed Sponsors

collaborator

JP Moulton Charitable Foundation

OTHER

collaborator

PRO.MED.CS Praha a.s.

UNKNOWN

collaborator

Clinical Trials Research Unit, University of Sheffield

UNKNOWN

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT03840005 - "Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The UP Study" | Biotech Hunter | Biotech Hunter